Special considerations on TAVI implanted in bicuspid aortic valves: Experience of Institute of Cardiology in Warsaw, Poland

Abstract Since the advent of transcatheter aortic valve implantation (TAVI), bicuspid aortic valves (BAVs) have been considered relative contraindication for this procedure. Patients with BAV were excluded from the majority of large clinical TAVI trials. However, the development of the implantation technique and further studies have proven this method feasible and safe also in BAVs. Nowadays some clinicians claim that BAV should no longer be a contraindication. Nevertheless some special aspects of the unique anatomy need to be taken into consideration when qualifying patients for this procedure. In our center since 2010 a total number of 28 patients with bicuspid aortic valve stenosis underwent TAVI.